Comparison of complications after D2 and D3 dissection for gastric cancer

被引:0
|
作者
Bostanci, EB [1 ]
Yol, S [1 ]
Kayaalp, C [1 ]
Ozogul, Y [1 ]
Aydin, C [1 ]
Atalay, F [1 ]
Akoglu, M [1 ]
机构
[1] Turkiye Yuksek Ihtisas Hosp, Dept Gastrointestinal Surg, Ankara, Turkey
来源
EJSO | 2004年 / 30卷 / 01期
关键词
gastric cancer; gastrectomy; lymph node dissection; mortality; morbidity;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. D3 dissection is accepted as having higher rates of mortality and morbidity than D2 dissection. In this study, we aimed to evaluate the mortality and morbidity rates of D3 dissection in our department and to compare these with mortality and morbidity after D2 dissection. Patients and methods. All patients who underwent radical gastric resection with lymph node dissection for gastric adenocarcinoma between June 1999 and June 2002 were evaluated. Clinicopathologic features of the tumour, the resection and lymphadenectomy, the postoperative mortality and morbidity were analysed. Results. There were 359 patients admitted for the treatment of gastric cancer. One hundred twenty four underwent palliative resection and 134 underwent resection with curative intent. Of 34/134 patients, underwent gastric resection with D3 dissection, and 100 underwent D2 dissection. The overall operative mortality rate of D2 and D3 dissections was 1 and 8.8%, respectively (p < 0.05). The relaparotomy rate was almost doubled in D3 dissection group (11.8% vs. 6%) but this difference was not statistically significant. D3 dissection was also associated with an increase in morbidity (35.3% vs. 10%, p < 0.05). Conclusions. This study indicates that D3 dissection can be performed with reasonable safety. It may be a useful alternative procedure in advanced cases for which additional risks of surgical morbidity and mortality are felt to be outweighed by potential benefits to patients. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:20 / 25
页数:6
相关论文
共 50 条
  • [41] Circadian motor behaviour of the rat after chronic treatment with a selective D3 and a D2/D3 antagonist
    Baier, PC
    Koch, R
    Virley, DJ
    Trenkwalder, C
    MOVEMENT DISORDERS, 2004, 19 : S40 - S41
  • [42] Circadian motor behaviour in the rat after chronic treatment with a selective D3 or a D2/D3 antagonist
    Baier, P. C.
    Koch, R.
    Virley, D. J.
    Trenkwalder, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 302 - 302
  • [43] Acute D2/D3 dopaminergic agonism but chronic D2/D3 antagonism prevents NMDA antagonist neurotoxicity
    Farber, Nuri B.
    Nemmers, Brian
    Noguchi, Kevin K.
    BIOLOGICAL PSYCHIATRY, 2006, 60 (06) : 630 - 638
  • [44] D2 vs D2 plus para-aortic lymph node dissection for advanced gastric cancer
    Ozmen, Mehmet Mahir
    Zulfikaroglu, Baris
    Ozmen, Fusun
    Moran, Munevver
    Ozalp, Necdet
    Seckin, Selda
    TURKISH JOURNAL OF SURGERY, 2021, 37 (01) : 49 - 58
  • [45] Comparison of Standard D2 and Limited Lymph Node Dissection in Elderly Patients with Advanced Gastric Cancer
    Ko, Chang Seok
    Jheong, Jin Ho
    Jeong, Seong-A
    Kim, Byung Sik
    Yook, Jeong Hwan
    Yoo, Moon-Won
    Kim, Beom Su
    Lee, In-Seob
    Kim, Sehee
    Gong, Chung Sik
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (08) : 5076 - 5082
  • [46] Comparison of Standard D2 and Limited Lymph Node Dissection in Elderly Patients with Advanced Gastric Cancer
    Chang Seok Ko
    Jin Ho Jheong
    Seong-A. Jeong
    Byung Sik Kim
    Jeong Hwan Yook
    Moon-Won Yoo
    Beom Su Kim
    In-Seob Lee
    Sehee Kim
    Chung Sik Gong
    Annals of Surgical Oncology, 2022, 29 : 5076 - 5082
  • [47] Vitamin D2 vs. D3
    David, Madeleine
    JOURNAL OF COMPLEMENTARY MEDICINE, 2007, 6 (06): : 7 - 7
  • [48] Comparison of response to vitamin D2 with vitamin D3 in children with nutritional rickets
    Thacher, T. D.
    Fischer, P. R.
    Obadofin, M. O.
    Levine, M. A.
    Singh, R. J.
    Pettifor, J. M.
    BONE, 2009, 45 : S102 - S102
  • [49] Efficacy of adjuvant XELOX and FOLFOX6 chemotherapy after D2 dissection for gastric cancer
    Wu, Ying
    Wei, Zhe-Wei
    He, Yu-Long
    Schwarz, Roderich E.
    Smith, David D.
    Xia, Guang-Kai
    Zhang, Chang-Hua
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (21) : 3309 - 3315
  • [50] Efficacy of adjuvant XELOX and FOLFOX6 chemotherapy after D2 dissection for gastric cancer
    Ying Wu
    Zhe-Wei Wei
    Yu-Long He
    Roderich E Schwarz
    David D Smith
    Guang-Kai Xia
    Chang-Hua Zhang
    World Journal of Gastroenterology, 2013, (21) : 3309 - 3315